Table 1.
Pilot study. Women: Measured and calculated parameters in tertiles (T1‐T3) of serum creatinine
T1 (N = 52, 0.38‐0.79 mg/dL) | T2 (N = 51, 0.79‐0.94 mg/dL) | T3 (N = 52, 0.95‐6.65 mg/dL) | |
---|---|---|---|
Age (y) | 42.5 (33.5‐55.5) | 50.0 (32.5‐61.0) | 45.5 (37.5‐55.5) |
Serum creatinine (mg/dL) | 0.72 (0.66‐0.77) | 0.86 (0.82‐0.89) | 1.23 (1.02‐1.99) |
CA125 (kU/L) | 13.2 (8.9‐17.8) | 11.6 (8.3‐17.9) | 17.6 (11.1‐28.4) |
HE4 (pmol/L) | 52.6 (43.8‐70.0) | 53.7 (45.6‐70.9) | 142.0 (84.8‐2272.8) |
ROMA (%) | 8.5 (6.2‐14.8) | 9.1 (5.9‐14.3) | 39.6 (18.8‐68.0) |
HE4, human epididymis protein 4; ROMA, Risk of Ovarian Malignancy Algorithm.
Divide by 0.01131 to convert creatinine from mg/dL to μmol/L. Data are given as median (interquartile range).